Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 53229 

6. Budget (Not Scored) 

Is the itemized budget for conducting 

the project, along with justification, 

reasonable and consistent with stated 

objectives, the five-year strategy and 

goals of the President’s Emergency Plan 

and Emergency Plan, and planned 

program activities? 

V.2. Review and Selection Process 

The HHS/CDC Procurement and 

Grants Office (PGO) staff will review 

applications for completeness, and HHS 

Global AIDS program will review them 

for responsiveness. Incomplete 

applications and applications that are 

non-responsive to the eligibility criteria 

will not advance through the review 

process. Applicants will receive 

notification that their application did 

not meet submission requirements. 

An objective review panel will 

evaluate complete and responsive 

applications according to the criteria 

listed in the ‘‘V.1. Criteria’’ section 

above. All persons who serve on the 

panel will be external to the U.S. 

Government Country Program Office. 

The panel may include both Federal and 

non-Federal participants. 

In addition, the following factors 

could affect the funding decision: 

While U.S.-based organizations are 

eligible to apply, we will give 

preference to existing national/ 

Tanzanian organizations. It is possible 

for one organization to apply as lead 

grantee with a plan that includes 

partnering with other organizations, 

preferably local. Although matching 

funds are not required, preference will 

be go to organizations that can leverage 

additional funds to contribute to 

program goals. 

Applications will be funded in order 

by score and rank determined by the 

review panel. HHS/CDC will provide 

justification for any decision to fund out 

of rank order. 

In addition, the following factors may 

affect the funding decision: 

• Maintaining geographic diversity 

V.3. Anticipated Announcement and 

Award Dates 

October 30, 2005. 

VI. Award Administration Information 

VI.1. Award Notices 

Successful applicants will receive a 

Notice of Award (NoA) from the HHS/ 

CDC Procurement and Grants Office. 

The NoA shall be the only binding, 

authorizing document between the 

recipient and HHS/CDC. An authorized 

Grants Management Officer will sign the 

NoA and mail it to the recipient fiscal 

officer identified in the application. 

Unsuccessful applicants will receive 

notification of the results of the 

application review by mail. 

VI.2. Administrative and National 

Policy Requirements 

45 CFR Part 74 and Part 92 

For more information on the Code of 

Federal Regulations, see the National 

Archives and Records Administration at 

the following Internet address: http:// 

www.access.gpo.gov/nara/cfr/cfr-tablesearch.html. 

The following additional 

requirements apply to this project: 

• AR–4 HIV/AIDS Confidentiality 

Provisions. 

• AR–6 Patient Care. 

• AR–8 Public Health System 

Reporting Requirements. 

• AR–12 Lobbying Restrictions. 

• AR–14 Accounting System 

Requirements. 

Applicants can find additional 

information on these requirements on 

the HHS/CDC Web site at the following 

Internet address: http://www.cdc.gov/ 

od/pgo/funding/ARs.htm. 

You need to include an additional 

Certifications form from the PHS5161–

1 application in the Grants.gov 

electronic submission only. Please refer 

to http://www.cdc.gov/od/pgo/funding/ 

PHS5161–1-Certificates.PDF. Once you 

have filled out the form, please attach it 

to the Grants.gov submission as Other 

Attachment Forms. 

VI.3. Reporting Requirements 

You must provide HHS/CDC with an 

original, plus two hard copies, of the 

following reports: 

1. Interim progress report, due no less 

than 90 days before the end of the 

budget period. The progress report will 

serve as your non-competing 

continuation application, and must 

contain the following elements: 

a. Current Budget Period Activities 

Objectives. 

b. Current Budget Period Financial 

Progress. 

c. New Budget Period Program 

Proposed Activity Objectives. 

d. Budget. 

e. Measures of Effectiveness, 

including progress against the 

numerical goals of the President’s 

Emergency Plan for AIDS Relief for 

Tanzania. 

f. Additional Requested Information. 

2. Annual progress report, due no 

later than 90 days after the end of the 

budget period. 

3. Financial status report, due no later 

than 90 days after the end of the budget 

period. 

4. Final financial and performance 

reports, due no later than 90 days after 

the end of the project period. 

Recipients must mail these reports to 

the Grants Management or Contract 

Specialist listed in the ‘‘Agency 

Contacts’’ section of this announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. 

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, U.S. Department of Health and 

Human Services, 2920 Brandywine 

Road, Atlanta, GA 30341. Telephone: 

770–488–2700. 

For program technical assistance, 

contact: Cecil Threat, Project Officer, 

Global AIDS Program, c/o American 

Embassy, 2140 Dar es Salaam Place, 

Washington, DC 20521–2140. 

Telephone: 255 22 212 1407. Cell: 255 

744 222986. Fax: 255 22 212 1462. Email: Cthreat@cdc.gov. 

For financial, grants management, or 

budget assistance, contact: Diane 

Flournoy, Grants Management 

Specialist, CDC Procurement and Grants 

Office, U.S. Department of Health and 

Human Services, 2920 Brandywine 

Road, Atlanta, GA 30341. Telephone: 

770–488–2072. E-mail: dmf6@cdc.gov. 

VIII. Other Information 

Applicants can find this and other 

HHS funding opportunity 

announcements on the HHS/CDC Web 

site, Internet address: www.cdc.gov 

(click on ‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements’’), and on the 

Web site of the HHS Office of Global 

Health Affairs, Internet address: 

www.globalhealth.gov. 

Dated: August 31, 2005. 

William P. Nichols, 

Director, Procurement and Grants Office, 

Centers for Disease Control and Prevention, 

U.S. Department of Health and Human 

Services. 

[FR Doc. 05–17679 Filed 9–6–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[ATSDR 213] 

Fees for Sanitation Inspections of 

Cruise Ships 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces fees 

for vessel sanitation inspections for 

53230 Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 

1 Gross register tonnage in cubic feet, as shown in 

Lloyd’s Register of Shipping. 

fiscal year 2006 (October 1, 2005, 

through September 30, 2006). 

FOR FURTHER INFORMATION CONTACT: 

David Forney, Chief, Vessel Sanitation 

Program, Division of Emergency and 

Environmental Health Services (EEHS), 

National Center for Environmental 

Health (NCEH), telephone (770) 488–

7333 or e-mail DForney@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose and Background 

The fee schedule for sanitation 

inspections of passenger cruise ships 

inspected under the Vessel Sanitation 

Program (VSP) was first published in 

the Federal Register on November 24, 

1987 (52 FR 45019), and CDC began 

collecting fees on March 1, 1988. Since 

then, CDC has published the fee 

schedule annually. This notice 

announces fees effective October 1, 

2005. The formula used to determine 

the fees is as follows: 

Average Cost Per Inspection = Total 

Cost of VSP ÷ Weight Number of Annual 

Inspection 

The average cost per inspection is 

multiplied by a size/cost factor to 

determine the fee for vessels in each 

size category. The size/cost factor was 

established in the proposed fee schedule 

published in the Federal Register on 

July 17, 1987 (52 FR 27060), and revised 

in a schedule published in the Federal 

Register on November 28, 1989 (54 FR 

48942). The revised size/cost factor is 

presented in Appendix A. 

Fees 

The fee schedule (Appendix A) will 

be effective October 1, 2005, through 

September 30, 2006. The fee schedule, 

which became effective October 1, 2001, 

will remain the same in Fiscal year 

2006. If travel expenses continue to 

increase, the fees may be adjusted before 

September 30, 2006, since travel 

constitutes a sizable portion of VSP’s 

costs. If an adjustment is necessary, a 

notice will be published in the Federal 

Register 30 days before the effective 

date. 

Applicability 

The fees will apply to all passenger 

cruise vessels for which inspections are 

conducted as part of CDC’s VSP. 

Dated: August 30, 2005. 

Kenneth Rose, 

Acting Director, Centers for Disease Control 

and Prevention (CDC), NCEH/ATSDR Office 

of Policy, Planning, and Evaluation. 

Appendix A 

SIZE/COST FACTOR

Vessel size GRT 1

Average 

cost ($U.S.) 

per GRT 

Extra Small ............................................................................................................................................................ > 3,001 0.25 

Small ...................................................................................................................................................................... 3,001–15,000 0.50 

Medium .................................................................................................................................................................. 15,001–30,000 1.00 

Large ...................................................................................................................................................................... 30,001–60,000 1.50 

Extra Large ............................................................................................................................................................ > 60,000 2.00 

FEE SCHEDULE OCTOBER 1, 2005–SEPTEMBER 30, 2006 

Vessel size GRT 1 Fee 

Extra Small ............................................................................................................................................................ > 3,001 1,150 

Small ...................................................................................................................................................................... 3,001–15,000 2,300 

Medium .................................................................................................................................................................. 15,001–30,000 4,600 

Large ...................................................................................................................................................................... 30,001–60,000 6,900 

Extra Large ............................................................................................................................................................ > 60,000 9,200 

Inspections and reinspections involve the 

same procedure, require the same amount of 

time, and are therefore charged at the same 

rate. 

[FR Doc. 05–17663 Filed 9–6–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

WERC: A Consortium for 

Environmental Education and 

Technology Development, Annual 

Environmental Design Contest; 

Availability of Sole Source Competing 

Continuation Cooperative Agreement; 

Request for Application: RFA-FDACFSAN–2005–3; Catalog of Federal 

Domestic Assistance Number 93.103 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

I. Funding Opportunity Description 

The Food and Drug Administration 

(FDA) is announcing its intent to accept 

and consider a single source competing 

continuation application for the award 

of a cooperative agreement to the WasteManagement Education and Research 

Consortium (WERC): A Consortium for 

Environmental Education and 

Technology Development to support the 

Annual Environmental Design Contest. 

FDA anticipates providing $106,000 

(direct and indirect costs combined) in 

fiscal year 2005 in support of this 

research project. Subject to the 

availability of Federal funds and 

successful performance, 4 additional 

years of support up to $106,000 (direct 

and indirect costs combined) per year 

will be available. FDA will support the 

research covered by this notice under 

the authority of section 301 of the 

Public Health Service Act (42 U.S.C. 

241). FDA’s research program is 

described in the Catalog of Federal 

Domestic Assistance No. 93.103. Before 

entering into cooperative agreements,